GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetics Generation Advancement Corp (ROCO:4160) » Definitions » Operating Margin %

Genetics Generation Advancement (ROCO:4160) Operating Margin % : 10.25% (As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Genetics Generation Advancement Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Genetics Generation Advancement's Operating Income for the three months ended in Sep. 2024 was NT$17.4 Mil. Genetics Generation Advancement's Revenue for the three months ended in Sep. 2024 was NT$170.2 Mil. Therefore, Genetics Generation Advancement's Operating Margin % for the quarter that ended in Sep. 2024 was 10.25%.

The historical rank and industry rank for Genetics Generation Advancement's Operating Margin % or its related term are showing as below:

ROCO:4160' s Operating Margin % Range Over the Past 10 Years
Min: -14.66   Med: 0.9   Max: 8.42
Current: 8.42


ROCO:4160's Operating Margin % is ranked better than
64.65% of 215 companies
in the Medical Diagnostics & Research industry
Industry Median: -0.97 vs ROCO:4160: 8.42

Genetics Generation Advancement's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Genetics Generation Advancement's Operating Income for the three months ended in Sep. 2024 was NT$17.4 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 was NT$55.9 Mil.


Genetics Generation Advancement Operating Margin % Historical Data

The historical data trend for Genetics Generation Advancement's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetics Generation Advancement Operating Margin % Chart

Genetics Generation Advancement Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.67 -4.81 -0.87 3.81 3.02

Genetics Generation Advancement Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.17 4.44 7.82 10.86 10.25

Competitive Comparison of Genetics Generation Advancement's Operating Margin %

For the Diagnostics & Research subindustry, Genetics Generation Advancement's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genetics Generation Advancement's Operating Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetics Generation Advancement's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Genetics Generation Advancement's Operating Margin % falls into.



Genetics Generation Advancement Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Genetics Generation Advancement's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=17.898 / 592.5
=3.02 %

Genetics Generation Advancement's Operating Margin % for the quarter that ended in Sep. 2024 is calculated as

Operating Margin %=Operating Income (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=17.435 / 170.159
=10.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genetics Generation Advancement  (ROCO:4160) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Genetics Generation Advancement Operating Margin % Related Terms

Thank you for viewing the detailed overview of Genetics Generation Advancement's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetics Generation Advancement Business Description

Traded in Other Exchanges
N/A
Address
No. 28, Lane 36, Xinhu 1st Road, 6th Floor, Neihu District, Taipei, TWN, 11494
Genetics Generation Advancement Corp is a Taiwan based company specialized in genetic testing and scientific information. It is engaged in providing services for the detection of genetic defects and prevention in newborns. Their main services include amniotic fluid chromosome chip screening, pre-implantation genetic diagnosis, and Molecular DNA testing diagnostics. The company is focused on the majority of areas of maternal precision medicine, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection, and precise health management. The business units of the company are the Genetic Testing Unit and Informatics business unit.

Genetics Generation Advancement Headlines

No Headlines